1441 – 1450 of 3134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Conflicts of interest issues. Response to Lucas et al.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A misunderstanding. Response to Dr Bilo et al.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re International survey on skin patch test procedures, attitudes and interpretation L.K. Tanno et al., WAOJ (2016) 9:8
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Commentary on "The Relationships Between Capacity and Performance in Youths With Cerebral Palsy Differ for GMFCS Levels"
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The quantified consumer: blind, non-informed and manipulated?
2017) In Internet Policy Review(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genredigering-vilka värderingar ska styra?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hög feber på akuten kopplades till lägre mortalitet vid svår sepsis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re : Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Streptomyces O-B one connection : a force within layered repression of a key developmental decision
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
(
- Contribution to journal › Debate/Note/Editorial